Moreover, Toor et al. observed that there was a high increase in levels of CD4+CTL-4+ T cells only in the PBMCs of CRC patients with advanced stages, suggesting that there is a relationship between increased levels of CTLA-4+ Tregs and CRC progression [7]. The gene discussed is CD4; the disease is colorectal carcinoma.